Ana Marín‐Niebla
- Pathology and Forensic Medicine top 10%
- Biochemistry top 5%
- Oncology
- Critical Care and Intensive Care Medicine top 5%
- Genetics top 10%
- Co-authors
- Santiago R. Leal‐NovalJ. LoscertalesÁngel Herruzo-AvilésJ.L. García GarmendiaAntonio Marín-CaballosVictoria Arellano‐OrdenMaría D. Rincón-FerrariAurelio Cayuela
- Topics
- Lymphoma Diagnosis and Treatment (22 papers)Chronic Lymphocytic Leukemia Research (13 papers)CAR-T cell therapy research (10 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- SpainUnited StatesSouth Korea
In The Last Decade
Ana Marín‐Niebla
33 papers receiving 535 citations
Peers
Comparison fields: 5 of 55
- Pathology and Forensic Medicine 177
- Biochemistry 173
- Oncology 129
- Critical Care and Intensive Care Medicine 93
- Genetics 87
Countries citing papers authored by Ana Marín‐Niebla
This map shows the geographic impact of Ana Marín‐Niebla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Marín‐Niebla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Marín‐Niebla more than expected).
Fields of papers citing papers by Ana Marín‐Niebla
This network shows the impact of papers produced by Ana Marín‐Niebla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Marín‐Niebla. The network helps show where Ana Marín‐Niebla may publish in the future.
Co-authorship network of co-authors of Ana Marín‐Niebla
This figure shows the co-authorship network connecting the top 25 collaborators of Ana Marín‐Niebla. A scholar is included among the top collaborators of Ana Marín‐Niebla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Marín‐Niebla. Ana Marín‐Niebla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 7 | |
| 7 | 2 | |
| 8 | 12 | |
| 9 | 2 | |
| 10 | 41 | |
| 11 | 2 | |
| 12 | 2 | |
| 13 | 4 | |
| 14 | 19 | |
| 15 | 81 | |
| 16 | 3 | |
| 17 | 31 | |
| 18 | Hemopoietic stem cell transplantation in refractory rheumatoid arthritis is not a contraindication for reconstructive surgery. | 1 |
| 19 | 5 | |
| 20 | 152 |
About Ana Marín‐Niebla
Ana Marín‐Niebla is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 35 papers that have together received 555 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (13 papers) and CAR-T cell therapy research (10 papers). The work is most often cited by research in Biochemistry (173 citations), Critical Care and Intensive Care Medicine (93 citations) and Pathology and Forensic Medicine (177 citations). Ana Marín‐Niebla has collaborated with scholars based in Spain, United States and South Korea. Frequent co-authors include Santiago R. Leal‐Noval, J. Loscertales, Ángel Herruzo-Avilés, J.L. García Garmendia, Antonio Marín-Caballos, Victoria Arellano‐Orden, María D. Rincón-Ferrari, Aurelio Cayuela, Carmen Ferrándiz‐Millón and Rosario Amaya‐Villar. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.